>
Switch to:

Calliditas Therapeutics AB Net Margin %

: -42,607.75% (As of Dec. 2020)
View and export this data going back to 2020. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Calliditas Therapeutics AB's Net Income for the three months ended in Dec. 2020 was $-20.38 Mil. Calliditas Therapeutics AB's Revenue for the three months ended in Dec. 2020 was $0.05 Mil. Therefore, Calliditas Therapeutics AB's net margin for the quarter that ended in Dec. 2020 was -42,607.75%.

NAS:CALT' s Net Margin % Range Over the Past 10 Years
Min: -49598.86   Med: -24808.25   Max: -17.63
Current: -49598.86

-49598.86
-17.63

NAS:CALT's Net Margin % is ranked lower than
99.99% of the 1021 Companies
in the Drug Manufacturers industry.

( Industry Median: 3.54 vs. NAS:CALT: -49598.86 )

Calliditas Therapeutics AB Net Margin % Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Net Margin % Premium Member Only - - - -17.63 -49,598.86

Calliditas Therapeutics AB Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49.48 -13,441.98 - - -42,607.75

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Calliditas Therapeutics AB Net Margin % Distribution

* The bar in red indicates where Calliditas Therapeutics AB's Net Margin % falls into.



Calliditas Therapeutics AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Calliditas Therapeutics AB's Net Margin for the fiscal year that ended in Dec. 2020 is calculated as

Net Margin=Net Income (A: Dec. 2020 )/Revenue (A: Dec. 2020 )
=-51.834128493023/0.10450670206024
=-49,598.86 %

Calliditas Therapeutics AB's Net Margin for the quarter that ended in Dec. 2020 is calculated as

Net Margin=Net Income (Q: Dec. 2020 )/Revenue (Q: Dec. 2020 )
=-20.378926474633/0.04782915426098
=-42,607.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Calliditas Therapeutics AB  (NAS:CALT) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Calliditas Therapeutics AB Net Margin % Related Terms


Calliditas Therapeutics AB Net Margin % Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)